NeuroSense Therapeutics Ltd. SEC filings NRSN

NeuroSense Therapeutics Ltd. has 314 filings in SEC EDGAR's recent list, going back to Aug 9, 2021. Its latest annual report, Form 20-F, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 2, 2026. The company's fiscal year ends on December 31.

NeuroSense Therapeutics Ltd. SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Nov 2, 2026 Nov 2, 2026
6-K Current report (foreign issuer) Oct 26, 2026 Oct 26, 2026
6-K Current report (foreign issuer) Oct 19, 2026 Oct 19, 2026
6-K Current report (foreign issuer) Oct 13, 2026 Oct 13, 2026
6-K Current report (foreign issuer) Oct 2, 2026 Oct 2, 2026
6-K Current report (foreign issuer) Sep 25, 2026 Jun 30, 2026
6-K Current report (foreign issuer) Sep 9, 2026 Sep 9, 2026
6-K Current report (foreign issuer) Aug 27, 2026 Aug 27, 2026
6-K Current report (foreign issuer) Aug 13, 2026 Aug 13, 2026
6-K Current report (foreign issuer) Aug 6, 2026 Aug 6, 2026
EFFECT Filing Jul 31, 2026 —
6-K Current report (foreign issuer) Jul 31, 2026 Jul 31, 2026
6-K Current report (foreign issuer) Jul 31, 2026 Jul 31, 2026
F-3/A Amendment no. 1 to form f-3 Jul 30, 2026 —
6-K Current report (foreign issuer) Jul 22, 2026 Jul 22, 2026
6-K Current report (foreign issuer) Jun 29, 2026 Jun 29, 2026
6-K Current report (foreign issuer) Jun 25, 2026 Jun 25, 2026
6-K Current report (foreign issuer) Jun 11, 2026 Jun 11, 2026
6-K Current report (foreign issuer) Jun 9, 2026 Jun 9, 2026
6-K Current report (foreign issuer) Jun 8, 2026 Jun 8, 2026
6-K Current report (foreign issuer) Apr 28, 2026 Apr 28, 2026
6-K Current report (foreign issuer) Apr 24, 2026 Apr 24, 2026
6-K Current report (foreign issuer) Apr 6, 2026 Apr 6, 2026
6-K Current report (foreign issuer) Apr 3, 2026 Apr 3, 2026
6-K Current report (foreign issuer) Mar 31, 2026 Mar 31, 2026
20-F Annual report (foreign issuer) Mar 31, 2026 Dec 31, 2025
6-K Current report (foreign issuer) Mar 24, 2026 Mar 24, 2026
6-K Current report (foreign issuer) Mar 16, 2026 Mar 16, 2026
6-K Current report (foreign issuer) Mar 11, 2026 Mar 11, 2026
6-K Current report (foreign issuer) Feb 18, 2026 Feb 18, 2026
6-K Current report (foreign issuer) Feb 13, 2026 Feb 13, 2026
6-K Current report (foreign issuer) Feb 9, 2026 Feb 9, 2026
F-3 Shelf registration (foreign issuer) Jan 29, 2026 —
6-K Current report (foreign issuer) Jan 6, 2026 Jan 6, 2026
6-K Current report (foreign issuer) Dec 22, 2025 Dec 22, 2025
6-K Current report (foreign issuer) Dec 8, 2025 Dec 8, 2025
6-K Current report (foreign issuer) Dec 4, 2025 Dec 4, 2025
424B3 Prospectus Nov 26, 2025 —
EFFECT Filing Nov 25, 2025 —
CORRESP Letter to the SEC Nov 24, 2025 —
6-K Current report (foreign issuer) Nov 24, 2025 Nov 24, 2025
6-K Current report (foreign issuer) Nov 21, 2025 Nov 21, 2025
F-3 Shelf registration (foreign issuer) Oct 28, 2025 —
6-K Current report (foreign issuer) Oct 6, 2025 Oct 6, 2025
6-K Current report (foreign issuer) Sep 25, 2025 Sep 25, 2025
6-K Current report (foreign issuer) Sep 10, 2025 Sep 10, 2025
6-K Current report (foreign issuer) Sep 4, 2025 Sep 4, 2025
6-K Current report (foreign issuer) Sep 4, 2025 Sep 4, 2025
6-K Current report (foreign issuer) Sep 2, 2025 Sep 2, 2025
6-K Current report (foreign issuer) Aug 21, 2025 Aug 21, 2025
6-K Current report (foreign issuer) Aug 20, 2025 Aug 20, 2025
EFFECT Filing Aug 18, 2025 —
EFFECT Filing Aug 18, 2025 —
S-8 Employee stock plan registration Aug 15, 2025 —
POS AM Post-effective amendment no. 2 to form f-1 Aug 15, 2025 —
POS AM Post-effective amendment no. 4 to form f-1 Aug 15, 2025 —
424B5 Prospectus supplement Aug 8, 2025 —
6-K Current report (foreign issuer) Aug 1, 2025 Jun 30, 2025
6-K Current report (foreign issuer) Jul 10, 2025 Jul 10, 2025
6-K Current report (foreign issuer) Jun 26, 2025 Jun 26, 2025
6-K Current report (foreign issuer) May 7, 2025 May 7, 2025
6-K Current report (foreign issuer) Apr 24, 2025 Apr 24, 2025
EFFECT Filing Apr 16, 2025 —
EFFECT Filing Apr 16, 2025 —
POS AM Post-effective amendment no 1 to form f-1 Apr 11, 2025 —
POS AM Post-effective amendment no. 3 to form f-1 Apr 11, 2025 —
6-K Current report (foreign issuer) Apr 7, 2025 Apr 7, 2025
20-F Annual report (foreign issuer) Apr 7, 2025 Dec 31, 2024
6-K Current report (foreign issuer) Mar 27, 2025 Mar 27, 2025
6-K Current report (foreign issuer) Mar 19, 2025 Mar 19, 2025
424B5 Prospectus supplement Feb 21, 2025 —
6-K Current report (foreign issuer) Feb 19, 2025 Feb 19, 2025
424B3 Prospectus Jan 17, 2025 —
EFFECT Filing Jan 16, 2025 —
CORRESP Letter to the SEC Jan 16, 2025 —
6-K Current report (foreign issuer) Jan 6, 2025 Jan 6, 2025
CORRESP Letter to the SEC Jan 6, 2025 —
UPLOAD Letter from the SEC Jan 3, 2025 —
F-3 Shelf registration (foreign issuer) Dec 26, 2024 —
6-K Current report (foreign issuer) Dec 23, 2024 Dec 23, 2024
6-K Current report (foreign issuer) Dec 18, 2024 Dec 18, 2024
6-K Current report (foreign issuer) Dec 17, 2024 Dec 17, 2024
EFFECT Filing Dec 12, 2024 —
424B3 Prospectus Dec 12, 2024 —
D Filing Dec 12, 2024 —
CORRESP Letter to the SEC Dec 12, 2024 —
UPLOAD Letter from the SEC Dec 12, 2024 —
6-K Current report (foreign issuer) Dec 11, 2024 Dec 11, 2024
F-3 Shelf registration (foreign issuer) Dec 6, 2024 —
6-K Current report (foreign issuer) Dec 4, 2024 Dec 4, 2024
6-K Current report (foreign issuer) Dec 2, 2024 Dec 2, 2024
EFFECT Filing Nov 22, 2024 —
424B3 Prospectus Nov 22, 2024 —
CORRESP Letter to the SEC Nov 21, 2024 —
UPLOAD Letter from the SEC Nov 21, 2024 —
F-1 Registration statement (foreign issuer) Nov 19, 2024 —
6-K Current report (foreign issuer) Nov 12, 2024 Nov 12, 2024
6-K Current report (foreign issuer) Oct 31, 2024 Oct 31, 2024
6-K Current report (foreign issuer) Oct 30, 2024 Oct 30, 2024
6-K Current report (foreign issuer) Oct 28, 2024 Oct 28, 2024
6-K Current report (foreign issuer) Oct 24, 2024 Oct 24, 2024
6-K Current report (foreign issuer) Oct 15, 2024 Oct 15, 2024
6-K Current report (foreign issuer) Oct 9, 2024 Oct 9, 2024
EFFECT Filing Oct 4, 2024 —
POS AM Post-effective amendment Oct 1, 2024 —
6-K Current report (foreign issuer) Sep 30, 2024 Jun 30, 2024
6-K Current report (foreign issuer) Sep 24, 2024 Sep 24, 2024
6-K Current report (foreign issuer) Sep 16, 2024 Sep 16, 2024
6-K Current report (foreign issuer) Sep 9, 2024 Sep 9, 2024
6-K Current report (foreign issuer) Aug 30, 2024 Aug 30, 2024
6-K Current report (foreign issuer) Aug 28, 2024 Aug 28, 2024
6-K Current report (foreign issuer) Aug 26, 2024 Aug 26, 2024
6-K Current report (foreign issuer) Aug 16, 2024 Aug 16, 2024
424B5 Prospectus supplement Aug 16, 2024 —
6-K Current report (foreign issuer) Aug 7, 2024 Aug 7, 2024
6-K Current report (foreign issuer) Aug 1, 2024 Aug 1, 2024
6-K Current report (foreign issuer) Jul 9, 2024 Jul 9, 2024
6-K Current report (foreign issuer) Jul 3, 2024 Jul 3, 2024
6-K Current report (foreign issuer) Jul 1, 2024 Jul 1, 2024
424B3 Prospectus Jun 27, 2024 —
424B3 Prospectus Jun 27, 2024 —
6-K Current report (foreign issuer) Jun 27, 2024 Jun 27, 2024
6-K Current report (foreign issuer) Jun 24, 2024 Jun 24, 2024
6-K Current report (foreign issuer) Jun 21, 2024 Jun 21, 2024
424B3 Prospectus Jun 17, 2024 —
424B3 Prospectus Jun 17, 2024 —
6-K Current report (foreign issuer) Jun 17, 2024 Dec 31, 2023
6-K Current report (foreign issuer) May 28, 2024 May 28, 2024
6-K Current report (foreign issuer) May 23, 2024 May 23, 2024
EFFECT Filing May 22, 2024 —
424B3 Prospectus May 22, 2024 —
CORRESP Letter to the SEC May 21, 2024 —
F-1/A Amendment no. 1 to form f-1 May 20, 2024 —
6-K Current report (foreign issuer) May 20, 2024 May 20, 2024
UPLOAD Letter from the SEC May 14, 2024 —
6-K Current report (foreign issuer) May 14, 2024 May 14, 2024
F-1 Registration statement (foreign issuer) May 10, 2024 —
6-K Current report (foreign issuer) May 7, 2024 May 7, 2024
D Filing Apr 25, 2024 —
424B5 Prospectus supplement Apr 12, 2024 —
6-K Current report (foreign issuer) Apr 12, 2024 Apr 12, 2024
6-K Current report (foreign issuer) Apr 10, 2024 Apr 10, 2024
6-K Current report (foreign issuer) Apr 9, 2024 Apr 9, 2024
EFFECT Filing Apr 8, 2024 —
EFFECT Filing Apr 8, 2024 —
6-K Current report (foreign issuer) Apr 5, 2024 Apr 5, 2024
POS AM Post-effective amendment Apr 4, 2024 —
POS AM Post-effective amendment no. 4 to form f-1 Apr 4, 2024 —
20-F Annual report (foreign issuer) Apr 4, 2024 Dec 31, 2023
6-K Current report (foreign issuer) Feb 22, 2024 Feb 22, 2024
6-K Current report (foreign issuer) Feb 7, 2024 Feb 7, 2024
6-K Current report (foreign issuer) Jan 9, 2024 Jan 9, 2024
6-K Current report (foreign issuer) Jan 9, 2024 Jan 9, 2024
424B3 Prospectus Dec 27, 2023 —
6-K Current report (foreign issuer) Dec 27, 2023 Dec 27, 2023
6-K Current report (foreign issuer) Dec 21, 2023 Dec 21, 2023
424B3 Prospectus Dec 14, 2023 —
6-K Current report (foreign issuer) Dec 14, 2023 Dec 14, 2023
424B3 Prospectus Dec 5, 2023 —
424B3 Prospectus Dec 5, 2023 —
6-K Current report (foreign issuer) Dec 5, 2023 Dec 5, 2023
EFFECT Filing Dec 4, 2023 —
CORRESP Letter to the SEC Dec 4, 2023 —
POS AM Post-effective amendment no. 3 to form f-1 Dec 4, 2023 —
6-K Current report (foreign issuer) Nov 28, 2023 Nov 28, 2023
POS AM Post-effective amendment no. 2 to form f-1 Nov 21, 2023 —
6-K Current report (foreign issuer) Nov 13, 2023 Nov 13, 2023
6-K Current report (foreign issuer) Nov 6, 2023 Nov 6, 2023
6-K Current report (foreign issuer) Oct 17, 2023 Oct 17, 2023
6-K Current report (foreign issuer) Oct 4, 2023 Oct 4, 2023
6-K Current report (foreign issuer) Oct 2, 2023 Oct 2, 2023
6-K Current report (foreign issuer) Sep 29, 2023 Sep 29, 2023
6-K Current report (foreign issuer) Sep 20, 2023 Sep 20, 2023
6-K Current report (foreign issuer) Sep 19, 2023 Sep 19, 2023
6-K Current report (foreign issuer) Sep 12, 2023 Sep 12, 2023
424B3 Prospectus Sep 7, 2023 —
EFFECT Filing Sep 5, 2023 —
CORRESP Letter to the SEC Aug 31, 2023 —
F-1/A Registration statement Aug 31, 2023 —
6-K Current report (foreign issuer) Aug 16, 2023 Jun 30, 2023
CORRESP Letter to the SEC Aug 14, 2023 —
F-1/A Registration statement Aug 14, 2023 —
UPLOAD Letter from the SEC Aug 1, 2023 —
F-1 Registration statement (foreign issuer) Jul 21, 2023 —
6-K Current report (foreign issuer) Jul 6, 2023 Jul 6, 2023
D Filing Jul 5, 2023 —
6-K Current report (foreign issuer) Jun 23, 2023 Jun 23, 2023
424B5 Prospectus supplement Jun 23, 2023 —
424B5 Prospectus supplement Jun 22, 2023 —
6-K Current report (foreign issuer) Jun 13, 2023 Jun 13, 2023
6-K Current report (foreign issuer) Jun 8, 2023 Jun 8, 2023
6-K Current report (foreign issuer) Jun 1, 2023 Jun 1, 2023
6-K Current report (foreign issuer) May 31, 2023 May 31, 2023
6-K Current report (foreign issuer) May 25, 2023 May 25, 2023
6-K Current report (foreign issuer) May 15, 2023 May 15, 2023
6-K Current report (foreign issuer) May 2, 2023 May 2, 2023
6-K Current report (foreign issuer) May 2, 2023 May 2, 2023
6-K Current report (foreign issuer) Apr 26, 2023 Apr 26, 2023
6-K Current report (foreign issuer) Apr 20, 2023 Apr 20, 2023
6-K Current report (foreign issuer) Apr 17, 2023 Apr 17, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
NRSN (Nasdaq), NRSNW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Herzliya, Israel
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1875091

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.